Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENPEAKS: Erythropoietin for Neuroprotection in CABG Surgery
NCT00336466Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in neurocognitive disorder (NCD), sponsored by University of Calgary. Started Sep 2004; status: completed.
02
Drugs
erythropoietin
03
Conditions
neurocognitive disorder (NCD)
Beyond the preview
Go deeper on NCT00336466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336466.